Approval · Notice of Compliance 20777 · 2018
RANITIDINE: Notice of Compliance 20777
Issued April 23, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20777
- Date
- April 23, 2018
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RANITIDINE | 02385953 | Cancelled Post Market |
| RANITIDINE | 02385961 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB